
OSR Holdings, Inc. — Investor Relations & Filings
OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-02 | English | |
| PROXY STATEMENT | 2026-05-26 | English | |
| 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | |
| 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47937235 | CURRENT REPORT | 2026-06-02 | English | ||
| 47073266 | PROXY STATEMENT | 2026-05-26 | English | ||
| 45603271 | 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | ||
| 42032938 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | ||
| 39151751 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | ||
| 35420934 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English | ||
| 33910620 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-09 | English | ||
| 33256646 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-03 | English | ||
| 33191238 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-02 | English | ||
| 32013135 | 8-K Filing | 2026-01-27 | English | ||
| 13362203 | CURRENT REPORT | 2026-01-14 | English | ||
|
2025
4 filings
| |||||
| 13362205 | CURRENT REPORT | 2025-11-25 | English | ||
| 13362204 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 13362206 | Director's Dealing 2025 | 2025-10-24 | English | ||
| 13362208 | CURRENT REPORT | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioInfra Life Science Inc.
Develops multi-biomarker blood tests for early cancer scree…
|
266470 | KR | Professional, scientific and te… |
|
Biomark Diagnostics Inc.
Oncology liquid biopsy diagnostics using metabolomics and A…
|
BUX | CA | Professional, scientific and te… |
|
Biomind Labs
Developing novel pharmaceutical drugs for patients with neu…
|
BMND | CA | Professional, scientific and te… |
|
BioNexus Gene Lab Corp
Develops gene-based diagnostics for early detection of dise…
|
BGLC | US | Professional, scientific and te… |
|
Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-rela…
|
ALBPS | FR | Professional, scientific and te… |
|
BioRestorative Therapies, Inc.
Develops adult stem cell therapies for degenerative disc an…
|
BRTX | US | Professional, scientific and te… |
|
BioSenic SA
Develops therapies for autoimmune diseases, inflammation, a…
|
BIOS | BE | Professional, scientific and te… |
|
BIOTECH
A biotechnology group offering preclinical services, intein…
|
BST | ES | Professional, scientific and te… |
|
BIOTRON LIMITED
Clinical-stage developer of small molecule antiviral drugs …
|
BIT | AU | Professional, scientific and te… |
|
BioVaxys Technology Corp.
Clinical-stage biopharma developing novel immunotherapy ass…
|
BIOV | CA | Professional, scientific and te… |
OSR Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OSR Holdings, Inc. (id: 35169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.